Axtria, which provides data analytics tools and software for life sciences industry, is planning to recruit around 1,000 data analysts and IT engineers in two years, said CEO Jaswinder Chadha.
Recently, Axtria received a $150 million growth investment from Bain Capital Tech Opportunities. The funding will enable Axtria to consolidate its position in cloud software and artificial intelligence (AI) by rapidly expanding its suite of life sciences focused SaaS platforms.
Axtria’s AI-powered platforms include Axtria DataMAx for data management, Axtria InsightsMAx for analytics, and Axtria SalesIQ and Axtria CustomerIQ for omnichannel commercial operations.
At present, Axtria supports more than 100 life sciences companies, including 12 of the top 20 global leaders with its cutting-edge software solutions. The company has been recognized for its growth in the Inc. 5000, Deloitte Technology Fast 500, NJBIZ Fast 50, SmartCEO Future 50, and Red Herring 100 rankings.
Bain Capital has experience across the life sciences ecosystem, having invested in the growth of Cerevel Therapeutics, Atea Pharmaceuticals, and SpringWorks Therapeutics. The firm has scaled a wide range of healthcare technology companies including HST Pathways, IQVIA, Waystar, and Zelis.